Lu Yan

690 total citations
41 papers, 476 citations indexed

About

Lu Yan is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Lu Yan has authored 41 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 21 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in Lu Yan's work include Pulmonary Hypertension Research and Treatments (27 papers), Cardiovascular Function and Risk Factors (10 papers) and Cardiovascular Issues in Pregnancy (7 papers). Lu Yan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (27 papers), Cardiovascular Function and Risk Factors (10 papers) and Cardiovascular Issues in Pregnancy (7 papers). Lu Yan collaborates with scholars based in China, Italy and United States. Lu Yan's co-authors include Zhihui Zhao, Zhihong Liu, Qi Jin, Qin Luo, Qing Zhao, Yi Zhang, Xin Li, Xue Yu, Anqi Duan and Changming Xiong and has published in prestigious journals such as PLoS ONE, Medicine and Journal of Cellular Biochemistry.

In The Last Decade

Lu Yan

41 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Yan China 13 261 191 134 107 68 41 476
Rintaro Nishimura Japan 14 360 1.4× 172 0.9× 160 1.2× 51 0.5× 69 1.0× 37 545
Marco Morale Italy 8 88 0.3× 153 0.8× 58 0.4× 44 0.4× 82 1.2× 14 484
K Saji Japan 8 211 0.8× 203 1.1× 147 1.1× 16 0.1× 62 0.9× 17 423
Xi-Qi Xu China 10 195 0.7× 179 0.9× 123 0.9× 32 0.3× 45 0.7× 28 392
Makiko Oboshi Japan 10 176 0.7× 85 0.4× 87 0.6× 44 0.4× 45 0.7× 28 369
Pei Zhu China 12 51 0.2× 162 0.8× 92 0.7× 60 0.6× 79 1.2× 46 396
Jennifer I. Drake United States 8 469 1.8× 314 1.6× 134 1.0× 55 0.5× 90 1.3× 11 569
Zhenjun Ji China 11 56 0.2× 128 0.7× 164 1.2× 58 0.5× 78 1.1× 42 422
Kristien Winckers Netherlands 11 100 0.4× 233 1.2× 68 0.5× 41 0.4× 76 1.1× 15 571
F Numano Japan 12 301 1.2× 117 0.6× 57 0.4× 23 0.2× 86 1.3× 32 505

Countries citing papers authored by Lu Yan

Since Specialization
Citations

This map shows the geographic impact of Lu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Yan more than expected).

Fields of papers citing papers by Lu Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Yan. The network helps show where Lu Yan may publish in the future.

Co-authorship network of co-authors of Lu Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Yan. A scholar is included among the top collaborators of Lu Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Yan. Lu Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yujing, et al.. (2024). The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C/ALKBH5 axis. PLoS ONE. 19(1). e0290986–e0290986. 5 indexed citations
2.
Wang, Mengyao, Lu Yan, Yang Tian, et al.. (2024). Genome-Wide Identification of bZIP Transcription Factors in Cymbidium ensifolium and Analysis of Their Expression under Low-Temperature Stress. Plants. 13(2). 219–219. 5 indexed citations
3.
Duan, Anqi, Zhihua Huang, Zhihui Zhao, et al.. (2023). The potential of cystatin C as a predictive biomarker in pulmonary hypertension. BMC Pulmonary Medicine. 23(1). 311–311. 6 indexed citations
4.
Li, Xin, Yi Zhang, Qi Jin, et al.. (2022). Predictors of early response to balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Therapeutic Advances in Respiratory Disease. 16. 2673717329–2673717329. 2 indexed citations
5.
Huang, Zhihua, Anqi Duan, Zhihui Zhao, et al.. (2022). Implication of prolonged nocturnal hypoxemia and obstructive sleep apnea for pulmonary hemodynamics in patients being evaluated for pulmonary hypertension: a retrospective study. Journal of Clinical Sleep Medicine. 19(2). 213–223. 14 indexed citations
6.
Duan, Anqi, Zhihua Huang, Zhihui Zhao, et al.. (2022). Development and Validation of a Nomogram for Predicting Obstructive Sleep Apnea in Patients with Pulmonary Arterial Hypertension. Nature and Science of Sleep. Volume 14. 1375–1386. 4 indexed citations
7.
Duan, Anqi, Zhihua Huang, Zhihui Zhao, et al.. (2022). The comorbidity burden and disease phenotype in pre-capillary pulmonary hypertension: The contributing role of obstructive sleep apnea. Sleep Medicine. 101. 146–153. 3 indexed citations
8.
Li, Xin, Anqi Duan, Qi Jin, et al.. (2022). Exercise Feature and Predictor of Prognosis in Patients with Pulmonary Artery Stenosis-Associated Pulmonary Hypertension. ESC Heart Failure. 9(6). 4198–4208. 2 indexed citations
9.
Zhang, Yi, Xin Li, Qi Jin, et al.. (2022). The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty. Respiratory Research. 23(1). 312–312. 5 indexed citations
10.
Zhang, Yi, Xin Li, Qin Luo, et al.. (2022). Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 9. 795420–795420. 4 indexed citations
11.
12.
Li, Xin, Yi Zhang, Qin Luo, et al.. (2021). Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 8. 762267–762267. 5 indexed citations
13.
Luo, Qin, Xue Yu, Zhihui Zhao, et al.. (2021). The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension. Journal of Thoracic Disease. 13(1). 178–188. 9 indexed citations
14.
Zhang, Yi, Qi Jin, Zhihui Zhao, et al.. (2021). Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension. Frontiers in Cardiovascular Medicine. 8. 699904–699904. 6 indexed citations
15.
Jin, Qi, Zhihui Zhao, Qin Luo, et al.. (2020). Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: State of the art. World Journal of Clinical Cases. 8(13). 2679–2702. 24 indexed citations
16.
Jin, Qi, Yi Tang, Zhihong Liu, et al.. (2020). Serum human epididymis protein 4 level as a predictor of clinical worsening in idiopathic pulmonary arterial hypertension: a pilot study. BMC Cardiovascular Disorders. 20(1). 175–175. 7 indexed citations
17.
Zhang, Yi, Xue Yu, Qi Jin, et al.. (2019). Advances in targeted therapy for chronic thromboembolic pulmonary hypertension. Heart Failure Reviews. 24(6). 949–965. 16 indexed citations
18.
Luo, Qin, Qi Jin, Zhihui Zhao, et al.. (2019). Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?. BMC Pulmonary Medicine. 19(1). 257–257. 3 indexed citations
19.
Li, Shaobin, Suihai Wang, Pietro Rubegni, et al.. (2018). Long noncoding RNA HAND2‐AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA‐21. Journal of Cellular Biochemistry. 120(6). 9564–9571. 41 indexed citations
20.
Jin, Qi, Qin Luo, Zhihui Zhao, et al.. (2018). Takotsubo syndrome with pulmonary embolism: a case report and literature review. BMC Cardiovascular Disorders. 18(1). 229–229. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rintaro Nishimura Breakdown of academic impact, for papers by Marco Morale Breakdown of academic impact, for papers by K Saji Breakdown of academic impact, for papers by Xi-Qi Xu Breakdown of academic impact, for papers by Makiko Oboshi Breakdown of academic impact, for papers by Pei Zhu Breakdown of academic impact, for papers by Jennifer I. Drake Breakdown of academic impact, for papers by Zhenjun Ji Breakdown of academic impact, for papers by Kristien Winckers Breakdown of academic impact, for papers by F Numano
Rankless by CCL
2026